You are currently viewing a new version of our website. To view the old version click .

Treatment of Mastitis in Dairy Cattle

This special issue belongs to the section “Antibiotics in Animal Health“.

Special Issue Information

Dear Colleagues,

Bovine mastitis is one of the most costly diseases affecting the dairy industry and is the most common condition affecting dairy cows where antibiotics are used. But in particular, mastitis is a painful disease that affects animal welfare. Over recent decades, the aims of mastitis treatment have been focused on maximizing cure rates, which has led to relatively simple treatment criteria resulting in predominantly blanket antimicrobial treatment. Not only uncritical substances are used. Only through careful and systematic scientific work can the therapy of mastitis be more targeted, so that comparable or even better cure rates can be achieved with fewer antibiotic doses. Our times require us to better balance cure rates, antibiotic selection and consumption, resistance avoidance and animal welfare.  This special issue seeks manuscripts that will help in the development of an evidence-based  targeted antibiotic therapy for mastitis in cattle. This includes not only manuscripts on clinical and pharmacological issues, but also those on decision-making tools, antimicrobial resistance, knowledge transfer in practice, economics of evidence-based therapies and animal welfare aspects.

Prof. Dr. Volker Krömker
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • mastitis therapy
  • antimicrobial resistance
  • evidence based antibiotic treatment
  • bacteriological cure
  • animal welfare
  • treatment decision making
  • transfer to practice

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Antibiotics - ISSN 2079-6382